Federated Hermes, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 3,641 shares of MIRM stock, worth $182,195. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,641
Previous 4,000
8.98%
Holding current value
$182,195
Previous $156,000
3.85%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MIRM
# of Institutions
210Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$329 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$229 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$162 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$140 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$130 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.84B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...